The Sirius University of Science and Technology will develop a gene therapy technology for hemophilia B. This was reported by the university's press service.
The development will form the basis for creating new drugs for the therapy of hereditary diseases.
Scientists have chosen hemophilia B as a model disease. New treatment strategies will significantly reduce the cost of treatment and prolong and improve the quality of life for patients.
Scientists plan to change the approach to treating hemophilia B. Instead of viral vectors, it was decided to use liposomal nanoparticles. They will contain genetic elements and a DNA editing system based on prime editing and base editing technologies.
They allow for the safe correction of genetic information and ensure a long-term therapeutic effect. Such an editing system is capable of making pinpoint, targeted edits of only one nucleotide in size.
It is worth noting that specialists from the Sirius University previously developed a new method for diagnosing age-related and oncological diseases by measuring vitamin B12 in human cells.
Read more on the topic:
A virtual human cell was developed in Sirius
An effective drug to fight cancer has been developed in Nizhny Novgorod
Rosatom has developed a new technology for producing a drug to treat cancer
Now on home
The service contains data on 45,000 fraudulent sites
Modernized engines may equip the Lada Azimut crossover
The price is 132 billion 265.8 million rubles
The manufacturer plans to strengthen its lineup of light commercial vehicles
The production of carbon fiber was organized in the shortest possible time
Electric vans will speed up the repair of urban transport infrastructure
Countries are working to synchronize regulations in the field of AI
The service's average daily audience is 55 million people
Stable Isomaterial Based on Metakaolin Has a Density Below 300 kg/m³
Re-identification quality improved twofold with new DynaMix method
Russians will be able to find out about debts online